What's New at The Body
HIV/AIDS News You Can Use
February 5, 2003
Wondering what Retrovirus 2003 will have to offer? David Scondras provides a short preview of next week's conference.recently approved rapid HIV test, from the 38,000 laboratories that currently administer it to more than 100,000 sites, including physician offices and HIV counseling centers. The decision means that potentially hundreds of thousands more people can be easily and quickly tested for HIV infection. here to take a look at the results from their study. interview with Alan Berkman, M.D. He's the medical director of a Bronx residence for individuals and families with AIDS, a treatment-access advocate and a former 1960s activist who spent more than eight years in prison. five new products have passed or are soon to pass under their scrutiny on the way to your medicine shelf. Bob Huff looks at these new drugs, in GMHC's Treatment Issues.
One of these drugs, atazanavir (Zrivada), is a once-a-day protease inhibitor expected to be approved soon for use in the U.S. Initial studies have shown that unlike other protease inhibitors, atazanavir does not appear to affect triglyceride or cholesterol levels. Check out this easy-to-read fact sheet.
To view The Body's collection of articles on atazanavir, click here.AIDS was stalking South Asians and warned that the region has only a narrow window of opportunity for turning back the disease. African AIDS initiative will be used to distribute condoms and generic drugs.
To read back over the HIV-related section of the President's State of the Union address, click here.
Interested in learning more about HIV/AIDS policy in the U.S. and throughout the world? Visit our Policy & Activism section for plenty of news and analysis.drug patents should not continue to block access to treatment in poor countries, the problem persists. AIDS Treatment News provides two recent examples from Nigeria and the World Trade Organization summit in Australia. HIV treatment educator. Just ask Carlos Santiago: He's a treatment educator in New York City who learned the hard way how to keep his audience interested in what he had to say. Read more about this important issue in this Treatment Action Network Alert.
In the United States, 13 state ADAPs have already closed enrollment to new clients or limited access to antiretroviral treatments. Adding expensive new drugs like T-20 (Fuzeon) or treatments for hepatitis C are out of the question for most ADAPs. Gregg Gonsalves writes a moving call to action, in GMHC's Treatment Issues.structured treatment interruptions didn't help people with HIV nearly as much as researchers had hoped. But is it possible that the study's findings aren't really as bad as people think? Treatment Action Group takes a closer look. here for an excellent review of how HPV-related problems are diagnosed and treated. quick overview of genital herpes in women: How it's contracted, what the symptoms are, and what treatments are available. a mother's use of anti-HIV drugs increases the risk that her baby will experience a seizure. That risk, however, was still very small (less than 1 in 1,000). treatment of chronic hepatitis C infection.
President's Budget Falls Short of Funds Needed for New Global AIDS Program -- PHR
The White House Gets Religion on AIDS in Africa
Where AIDS Stalks, Everyone Lives in Fear
Smallpox Vaccination and the Patient With HIV/AIDS